网站大量收购独家精品文档,联系QQ:2885784924

地塞米松和他克莫司对HaCaT细胞糖皮质激素受体和热休克蛋白90表达调节-皮肤病与性病学专业论文.docx

地塞米松和他克莫司对HaCaT细胞糖皮质激素受体和热休克蛋白90表达调节-皮肤病与性病学专业论文.docx

  1. 1、本文档共114页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
地塞米松和他克莫司对HaCaT细胞糖皮质激素受体和热休克蛋白90表达调节-皮肤病与性病学专业论文

第三军医大学博士学位论文 第三军医大学博士学位论文 PAGE PAGE 4 Effects of dexamethasone and tacrolimus on glucocorticoid receptor and heat shock protein 90 expressions in human HaCaT cells in vitro Abstract Background Topical glucocorticoid (GC) therapy is mainly a routine therapeutic modality for the treatment of inflammatory dermatoses. A low response or missing response to topical GC therapy, which is called tolerance or resistance to GC, often occurs during the treatment. The actions of GCs are mediated by the intracellular receptor, the glucocorticoid receptor (GR). Evidence obtained from some laboratories indicates that the decreased expression or affinity of GRα can alter the sensitivity of cells to GCs and the increased expression of GRβ may be associated with the ineffectiveness of GCs in the treatment of different diseases. Changes in the expression of heat shock protein 90 (HSP90), molecular chaperone of GR, lead to disequilibrium in the ratio of HSP90 and GR, which could cause attenuation of GC sensitivity. Down-regulation of GRα or up-regulation of GRβ induced by GC could partially account for tolerance or resistance to GC. In order to postpone or decrease occurrence of these phenomena, dermatologists usually apply GCs and non-GC anti-inflammatory agents alternately, which just was a kind of empirical prescription without experimental evidence. Tacrolimus ointment has shown remarkable efficacy in the treatment of inflammatory dermatoses. Some studies in vitro found that tacrolimus might induce activation of GRα in Hela cells or COS-7 cells. Down-regulation of GRα or up-regulation of GRβ induced by GC in cells suggests the necessity of controlling the duration of topical GC treatment. However, the subsequent changes of GR expression after withdrawal of GC remain unknown. Effects of tacrolimus, which appeared to potentially correlate with GC action, or tacrolimus in combination of GC, on expression of GR are still unclear. Dermal inflammation often involves different types of

您可能关注的文档

文档评论(0)

peili2018 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档